Conspicuity and evolution of lesions in Creutzfeldt-Jakob disease at diffusion-weighted imaging.

BACKGROUND AND PURPOSE Diffusion-weighted imaging can disclose distinct hyperintense lesions in Creutzfeldt-Jakob disease (CJD). However, these findings and chronologic changes of CJD at diffusion-weighted imaging have not been fully investigated. Our purpose was to assess the diagnostic value of diffusion-weighted imaging in depicting CJD-related lesions and in tracking the evolution of these lesions. We also compared the sensitivity of diffusion-weighted imaging in depicting CJD-related lesions to that of fluid-attenuated inversion recovery (FLAIR) imaging. METHODS We reviewed findings in 13 patients with a diagnosis of CJD who underwent MR imaging, including diffusion-weighted imaging. Nine patients were initially examined within 4 months of onset of symptoms (early stage), and eight were examined 4 months or later (late stage). We evaluated four items: 1) distribution of lesions at diffusion-weighted imaging, 2) conspicuity of lesions at diffusion-weighted imaging and FLAIR imaging, 3) chronologic changes in lesions at diffusion-weighted imaging, and 4) chronologic changes in lesions revealed by apparent diffusion coefficient (ADC) maps. RESULTS Patients had striatal lesions or cerebral cortical lesions or both. The thalamus was involved in only one patient, and the globus pallidus was spared in all patients. The sensitivity of diffusion-weighted imaging in depicting lesions was superior or at least equal to that of FLAIR imaging. Hyperintense lesions at diffusion-weighted imaging changed in extent and intensity over time. Unlike infarction, lesional ADC decreased for 2 weeks or longer. CONCLUSION The progressively hyperintense changes in the striata and cerebral cortices at diffusion-weighted imaging are considered characteristic of CJD. Diffusion-weighted imaging may be useful for the early diagnosis of CJD.

[1]  J. Cervós-Navarro,et al.  Focal involvement and lateralization in Creutzfeldt-Jakob disease: correlation of clinical, electroencephalographic and neuropathological findings. , 1992, European neurology.

[2]  L. Cartier,et al.  Computed tomography findings in 15 cases of Creutzfeldt-Jakob disease with histological verification. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[3]  W. Hacke,et al.  Magnetic resonance imaging in Creutzfeldt-Jakob disease: evidence of focal involvement of the cortex , 1997, Journal of neurology, neurosurgery, and psychiatry.

[4]  S. Prusiner,et al.  Regional mapping of prion proteins in brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Lin,et al.  Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease. , 1997, Archives of neurology.

[6]  J. Adair,et al.  Diffusion-weighted magnetic resonance imaging in probable Creutzfeldt-Jakob disease: a clinical-anatomic correlation. , 1999, Archives of neurology.

[7]  H. Urbach,et al.  MRI in sporadic Creutzfeldt-Jakob disease: Correlation with clinical and neuropathological data , 1998, Neuroradiology.

[8]  J. Provenzale,et al.  MR diagnosis of Creutzfeldt-Jakob disease: significance of high signal intensity of the basal ganglia. , 1994, AJR. American journal of roentgenology.

[9]  H. Gertz,et al.  Creutzfeldt‐Jakob disease , 1988, Neurology.

[10]  I. Zerr,et al.  MR imaging of Creutzfeldt-Jakob disease. , 1996, Radiology.

[11]  W. S. Monkhouse,et al.  GRAY'S ANATOMY , 1947 .

[12]  S. DeArmond,et al.  Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. , 1996, Archives of neurology.

[13]  H. Gertz,et al.  Creutzfeldt-Jakob disease: correlation of MRI and neuropathologic findings. , 1988, Neurology.

[14]  T. Erkinjuntti,et al.  Cerebral MR and CT Imaging in Creutzfeldt‐Jakob Disease , 1985, Journal of computer assisted tomography.

[15]  C. Gibbs,et al.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.

[16]  H. Fraser,et al.  Targeting of scrapie lesions and spread of agent via the retino-tectal projection , 1985, Brain Research.

[17]  K. Shinoda,et al.  Serial MRI in early Creutzfeldt-Jacob disease with a point mutation of prion protein at codon 180 , 1995, Neuroradiology.

[18]  J. Finsterer,et al.  Hypothyroid Myopathy with Unusually High Serum Creatine Kinase Values , 2000, Hormone Research in Paediatrics.

[19]  W. Robberecht,et al.  Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease , 1997, The Lancet.

[20]  T. Kitamoto,et al.  Human prion diseases with variant prion protein. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  Data on leisure accidents and injuries should be collated centrally , 1996, BMJ.

[22]  C. Filley,et al.  Diffusion-weighted MRI of right-hemisphere dysfunction in Creutzfeldt–Jakob disease , 1999, Neurology.

[23]  A. Elster,et al.  Cerebral infarction: time course of signal intensity changes on diffusion-weighted MR images. , 1998, AJR. American journal of roentgenology.

[24]  J. Ironside,et al.  Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt–Jakob disease , 2000, Neuropathology and applied neurobiology.

[25]  J. Ironside,et al.  Reporting of suspect new variant Creutzfeldt-Jakob disease , 1997, The Lancet.